Insights

Loading spinner
Gathering insights about CytoImmune Therapeutics

Similar companies to CytoImmune Therapeutics

CytoImmune Therapeutics Tech Stack

CytoImmune Therapeutics uses 8 technology products and services including jQuery Migrate, Slider Revolution, Priority Hints, and more. Explore CytoImmune Therapeutics's tech stack below.

  • jQuery Migrate
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Priority Hints
    Performance
  • PHP
    Programming Languages
  • TablePress
    Web Platform Extensions
  • Nginx
    Web Servers
  • Apache
    Web Servers
  • prettyPhoto
    Web Tools And Plugins

Media & News

CytoImmune Therapeutics's Email Address Formats

CytoImmune Therapeutics uses at least 1 format(s):
CytoImmune Therapeutics Email FormatsExamplePercentage
First@cytoimmune.comJohn@cytoimmune.com
40%
First.Last@cytoimmune.comJohn.Doe@cytoimmune.com
19%
Last@cytoimmune.comDoe@cytoimmune.com
1%
First@cytoimmune.comJohn@cytoimmune.com
40%

Frequently Asked Questions

What is CytoImmune Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
CytoImmune Therapeutics's official website is cytoimmune.com and has social profiles on LinkedIn.

What is CytoImmune Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
CytoImmune Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does CytoImmune Therapeutics have currently?

Minus sign iconPlus sign icon
As of December 2025, CytoImmune Therapeutics has approximately 51 employees across 1 continents, including North America. Key team members include Chief Executive Officer: J. E. V.Chief Medical Officer: R. V.President: W. R.. Explore CytoImmune Therapeutics's employee directory with LeadIQ.

What industry does CytoImmune Therapeutics belong to?

Minus sign iconPlus sign icon
CytoImmune Therapeutics operates in the Biotechnology Research industry.

What technology does CytoImmune Therapeutics use?

Minus sign iconPlus sign icon
CytoImmune Therapeutics's tech stack includes jQuery MigrateSlider RevolutionPriority HintsPHPTablePressNginxApacheprettyPhoto.

What is CytoImmune Therapeutics's email format?

Minus sign iconPlus sign icon
CytoImmune Therapeutics's email format typically follows the pattern of First@cytoimmune.com. Find more CytoImmune Therapeutics email formats with LeadIQ.

When was CytoImmune Therapeutics founded?

Minus sign iconPlus sign icon
CytoImmune Therapeutics was founded in 2019.

CytoImmune Therapeutics

Biotechnology ResearchCalifornia, United States51-200 Employees

CytoImmune Therapeutics, LLC develops novel, coordinated immunotherapy solutions for patients.

Our CoalesceNT™ platform harnesses the power of bispecific antibody (biAb) and chimeric antigen receptor (CAR) technology to coordinate an immune response with both natural killer (NK) and T cells. This combination of NK- and T-cell therapy expedites time-to-treatment and delivers a dynamic immune response that reflects natural immunity.

Section iconCompany Overview

SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2019
Employees
51-200

Section iconFunding & Financials

  • $1M$10M

    CytoImmune Therapeutics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    CytoImmune Therapeutics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.